Just another anecdote:
2/2007: First (and only) MS-exacerbation, started with Rebif
3/2008: First round of Campath (high dose; off-label)
5/2009-1/2010: Pregnancy (we had some little troubles to conceive), delivered a perfectly healthy baby
3/2010: Second round of Campath (high dose; off-label)
7/2010: Early miscarriage (surprise pregnancy); no chromosomal abnormalities found (had a D&C)
10/2010: ITP

I went to work fine, came home at night still feeling perfectly fine only to discover my legs were covered ...

I know there's been a discussion about this, but it seemed to focus on females. Have any of you males who've had campath either sperm banked before it, had any counselling about it or had any drop in fertility?

I was treated with my second round of Campath in early May. In June I started with a rash that first appeared on my head around my hairline. I initially thought it was the new shampoo I bought so I quit using it. The rash continued and popped up on my torso. I went to my neurologist/study doctor to let him have a look. He sent me to a dermatologist who confirmed that it was ...

Genzyme's Alemtuzumab for Treatment of Multiple Sclerosis Granted Fast Track Status by FDA


CAMBRIDGE, Mass., Jun 14, 2010 (BUSINESS WIRE) -- Genzyme Corporation /quotes/comstock/15*!genz/quotes/nls/genz (GENZ 49.50, +0.45, +0.92%) announced today that its alemtuzumab for multiple sclerosis development program has been granted Fast Track status by the U.S. Food and Drug Administration (FDA). This designation covers patients with relapsing-remitting forms of the disease.

The FDA's Fast Track program is designed to expedite the review of new ...

This forum has gotten very quiet lately. For those of you using Campath off-label or in one of the trials could you please report your condition?

I think that we all know the risks of an autoimmune disease if you take the campath option, but does anyone know if there is a risk of cancer? I think that in the phase 2 trial they had 3 cases of cancer in the campth group (breast, cervical and lymphoma) v. one in the control group (colon) which they felt was statistically irrelevant, although they felt that the lymphoma might be related to the ...

If and when they approve Campath late next year I fear the price of a round of treatment will jump from $5,000 to $25,000, especially since Genzyme would not be making much money on an MS treatment that only has to be used two years in a row every 4 years (and maybe even every 5-6 years). Shareholders, do the math: 2 years of Rebif = $52,000 (effective for only 2 years). 2 years of ...

I was considering ccvsi. I've got a request in at a vascular doctors office since I've been denied a second round of campath due to low lymphocyte counts that didn't rebound in time. After making the ccvsi call and gearing up to pursue it I got a call from my campath study neurologists office. Genzyme is making a tweak to the study protocol. Now at month 14 after the first dose if you didn't qualify ...

a one-two punch.....time will tell